A comparison between the neurocognitive profile of Huntington Disease-Like 2 and Huntington Disease: Exploring the presence of double dissociations

Applied Neuropsychology Adult ◽

10.1080/23279095.2020.1734810 ◽

2020 ◽

pp. 1-11

Author(s):

Aline Ferreira-Correia ◽

David G. Anderson ◽

Kate Cockcroft ◽

Amanda Krause

Keyword(s):

Huntington Disease ◽

Neurocognitive Profile ◽

Double Dissociations

Download Full-text

Don't be too strict with yourself! Rigid negative self-representation in healthy subjects mimics neurocognitive profile of depression for autobiographical memory

PsycEXTRA Dataset ◽

10.1037/e636952013-049 ◽

2013 ◽

Author(s):

Marco Sperduti ◽

Penelope Martinelli ◽

Sandrine Kalenzaga ◽

Thierry Gallarda ◽

Isabelle Amado ◽

...

Keyword(s):

Autobiographical Memory ◽

Healthy Subjects ◽

Neurocognitive Profile

Download Full-text

Progressive myoclonus epilepsy: a differential diagnosis from juvenile chorea Huntington disease

Neuropediatrics ◽

10.1055/s-0033-1337705 ◽

2013 ◽

Vol 44 (02) ◽

Author(s):

M Gosk ◽

F Laccone ◽

P Burfeind ◽

G Bernert

Keyword(s):

Differential Diagnosis ◽

Huntington Disease ◽

Chorea Huntington ◽

Progressive Myoclonus Epilepsy ◽

Myoclonus Epilepsy

Download Full-text

Attention Deficit in Neurofibromatosis Type 1: Part of the Neurocognitive Profile or Comorbidity?

Neuropediatrics ◽

10.1055/s-0034-1390548 ◽

2014 ◽

Vol 45 (S 01) ◽

Author(s):

M. Schulze ◽

S. Granström ◽

V. Mautner ◽

K. Lidzba

Keyword(s):

Neurofibromatosis Type 1 ◽

Attention Deficit ◽

Neurofibromatosis Type ◽

Neurocognitive Profile

Download Full-text

THE NEUROCOGNITIVE PROFILE OF SOUTH AFRICAN PRESCHOOL CHILDREN WITH NEUROFIBROMATOSIS 1

Neuropediatrics ◽

10.1055/s-2006-943619 ◽

2006 ◽

Vol 37 (S 1) ◽

Author(s):

V Ramanjam ◽

JM Wilmshurst ◽

C Adnams

Keyword(s):

Preschool Children ◽

South African ◽

Neurofibromatosis 1 ◽

Neurocognitive Profile

Download Full-text

Faculty Opinions recommendation of Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1019373.218521 ◽

2004 ◽

Author(s):

Thomas Neufeld

Keyword(s):

Mouse Models ◽

Huntington Disease ◽

Polyglutamine Expansions

Download Full-text

Faculty Opinions recommendation of Trehalose alleviates polyglutamine-mediated pathology in a mouse model of Huntington disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1017842.207466 ◽

2004 ◽

Author(s):

M Flint Beal

Keyword(s):

Mouse Model ◽

Huntington Disease

Download Full-text

Faculty Opinions recommendation of The right to ignore genetic status of late onset genetic disease in the genomic era; Prenatal testing for Huntington disease as a paradigm.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4003957.3763055 ◽

2010 ◽

Author(s):

Giovanni Neri

Keyword(s):

Huntington Disease ◽

Genetic Disease ◽

Prenatal Testing ◽

Genetic Status ◽

Download Full-text

Faculty Opinions recommendation of Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718086977.793485064 ◽

2013 ◽

Author(s):

George Perry

Keyword(s):

Huntington Disease ◽

Download Full-text

Faculty Opinions recommendation of Substance abuse may hasten motor onset of Huntington disease: Evaluating the Enroll-HD database.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.727261803.793537341 ◽

2017 ◽

Author(s):

Victor Fung ◽

Florence Chang

Keyword(s):

Substance Abuse ◽

Huntington Disease ◽

Download Full-text

Nanotechnology: its application in treating Neurodegenerative diseases

CNS & Neurological Disorders - Drug Targets ◽

10.2174/1871527319666200916121515 ◽

2020 ◽

Vol 19 ◽

Author(s):

Falaq Naz ◽

Yasir Hasan Siddique

Keyword(s):

Quality Of Life ◽

Neurodegenerative Diseases ◽

Blood Brain Barrier ◽

Huntington Disease ◽

Treatment Strategies ◽

Present Review ◽

Brain Barrier ◽

Treatment Level ◽

: Neurodegenerative diseases including Alzheimer’s, Parkinson’s and Huntington disease are have serious concern due to its effect on the quality of life of affected persons. Neurodegenerative diseases have some limitations for both diagnostic as well as at treatment level. Introducing nanotechnology, for the treatment of these diseases may contribute significantly in solving the problem. There are several treatment strategies for the neurodegenerative diseases, but their limitations are the entry into the due to the presence of the blood-brain barrier (BBB). The present review highlights the application of nanotechnology during last 20 years for the treatment of neurodegenerative diseases.

Download Full-text